These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 21682553

  • 1. Effects of a secondary prevention combination therapy with an aspirin, an ACE inhibitor and a statin on 1-year mortality of patients with acute myocardial infarction treated with a beta-blocker. Support for a polypill approach.
    Zeymer U, Jünger C, Zahn R, Bauer T, Bestehorn K, Senges J, Gitt A.
    Curr Med Res Opin; 2011 Aug; 27(8):1563-70. PubMed ID: 21682553
    [Abstract] [Full Text] [Related]

  • 2. Prognostic impact of acute beta-blocker therapy on top of aspirin and angiotensin-converting enzyme inhibitor therapy in consecutive patients with ST-elevation acute myocardial infarction.
    Wienbergen H, Zeymer U, Gitt AK, Juenger C, Schiele R, Heer T, Towae F, Senges J, MITRA PLUS Study Group.
    Am J Cardiol; 2007 May 01; 99(9):1208-11. PubMed ID: 17478143
    [Abstract] [Full Text] [Related]

  • 3. Suboptimal use of evidence-based medical therapy in patients with acute myocardial infarction from the Korea Acute Myocardial Infarction Registry: prescription rate, predictors, and prognostic value.
    Lee JH, Yang DH, Park HS, Cho Y, Jeong MH, Kim YJ, Kim KS, Hur SH, Seong IW, Hong TJ, Cho MC, Kim CJ, Jun JE, Park WH, Chae SC, Korea Acute Myocardial Infarction Registry Investigators.
    Am Heart J; 2010 Jun 01; 159(6):1012-9. PubMed ID: 20569714
    [Abstract] [Full Text] [Related]

  • 4. Association of early follow-up after acute myocardial infarction with higher rates of medication use.
    Daugherty SL, Ho PM, Spertus JA, Jones PG, Bach RG, Krumholz HM, Peterson ED, Rumsfeld JS, Masoudi FA.
    Arch Intern Med; 2008 Mar 10; 168(5):485-91; discussion 492. PubMed ID: 18332293
    [Abstract] [Full Text] [Related]

  • 5. [Effect of combined beta-blocker and angiotensin-converting enzyme inhibitor treatment on 1-year survival after acute myocardial infarction: findings of the PRIAMHO-II registry].
    Arós F, Loma-Osorio A, Vila J, López-Bescós L, Cuñat J, Rodríguez E, San José JM, Heras M, Marrugat J, Investigadores del PRIAMHO II.
    Rev Esp Cardiol; 2006 Apr 10; 59(4):313-20. PubMed ID: 16709383
    [Abstract] [Full Text] [Related]

  • 6. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.
    Vermeer NS, Bajorek BV.
    J Clin Pharm Ther; 2008 Dec 10; 33(6):591-601. PubMed ID: 19138236
    [Abstract] [Full Text] [Related]

  • 7. Drug prescriptions after acute myocardial infarction: dosage, compliance, and persistence.
    Simpson E, Beck C, Richard H, Eisenberg MJ, Pilote L.
    Am Heart J; 2003 Mar 10; 145(3):438-44. PubMed ID: 12660666
    [Abstract] [Full Text] [Related]

  • 8. Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study.
    Eagle KA, Kline-Rogers E, Goodman SG, Gurfinkel EP, Avezum A, Flather MD, Granger CB, Erickson S, White K, Steg PG.
    Am J Med; 2004 Jul 15; 117(2):73-81. PubMed ID: 15234641
    [Abstract] [Full Text] [Related]

  • 9. Preventive drug use in patients with a history of nonfatal myocardial infarction during 12-year follow-up in The Netherlands: a retrospective analysis.
    van der Elst ME, Bouvy ML, de Blaey CJ, de Boer A.
    Clin Ther; 2005 Nov 15; 27(11):1806-14. PubMed ID: 16368451
    [Abstract] [Full Text] [Related]

  • 10. Impact of combined secondary prevention therapy after myocardial infarction: data from a nationwide French registry.
    Danchin N, Cambou JP, Hanania G, Kadri Z, Genès N, Lablanche JM, Blanchard D, Vaur L, Clerson P, Guéret P, USIC 2000 investigators.
    Am Heart J; 2005 Dec 15; 150(6):1147-53. PubMed ID: 16338251
    [Abstract] [Full Text] [Related]

  • 11. Effects of receipt of chronic statin therapy before the onset of acute myocardial infarction: a retrospective study in patients undergoing primary percutaneous coronary intervention.
    Ishii H, Ichimiya S, Kanashiro M, Aoyama T, Ogawa Y, Murakami R, Amano T, Naruse K, Matsubara T, Murohara T.
    Clin Ther; 2006 Nov 15; 28(11):1812-9. PubMed ID: 17213001
    [Abstract] [Full Text] [Related]

  • 12. Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study.
    Bi Y, Gao R, Patel A, Su S, Gao W, Hu D, Huang D, Kong L, Qi W, Wu Y, Yang Y, Turnbull F, CPACS Investigators.
    Am Heart J; 2009 Mar 15; 157(3):509-516.e1. PubMed ID: 19249422
    [Abstract] [Full Text] [Related]

  • 13. Too little aspirin for secondary prevention after acute myocardial infarction in patients at high risk for cardiovascular events: Results from the MITRA study.
    Frilling B, Schiele R, Gitt AK, Zahn R, Schneider S, Glunz HG, Gieseler U, Jagodzinski E, Senges J, Maximal Individual Therapy in Acute Myocardial Infarction Study Group.
    Am Heart J; 2004 Aug 15; 148(2):306-11. PubMed ID: 15309001
    [Abstract] [Full Text] [Related]

  • 14. Adherence to ACC/AHA performance measures for myocardial infarction in six Middle-Eastern countries: association with in-hospital mortality and clinical characteristics.
    Longenecker JC, Alfaddagh A, Zubaid M, Rashed W, Ridha M, Alenezi F, Alhamdan R, Akbar M, Bulbanat BY, Al-Suwaidi J.
    Int J Cardiol; 2013 Aug 20; 167(4):1406-11. PubMed ID: 22578736
    [Abstract] [Full Text] [Related]

  • 15. Preoperative statin therapy is associated with reduced cardiac mortality after coronary artery bypass graft surgery.
    Collard CD, Body SC, Shernan SK, Wang S, Mangano DT, Multicenter Study of Perioperative Ischemia (MCSPI) Research Group, Inc, Ischemia Research and Education Foundation (IREF) Investigators.
    J Thorac Cardiovasc Surg; 2006 Aug 20; 132(2):392-400. PubMed ID: 16872968
    [Abstract] [Full Text] [Related]

  • 16. [Management of acute myocardial infarction in the experience of a community hospital. A prospective study].
    Tincani E, Mazzoli V, Bondi M.
    Minerva Cardioangiol; 1997 Aug 20; 45(7-8):335-47. PubMed ID: 9463169
    [Abstract] [Full Text] [Related]

  • 17. Effect of clopidogrel on 1-year mortality in hospital survivors of acute ST-segment elevation myocardial infarction in clinical practice.
    Zeymer U, Gitt AK, Jünger C, Heer T, Wienbergen H, Koeth O, Bauer T, Mark B, Zahn R, Gottwik M, Senges J, Acute COronary Syndromes (ACOS) registry investigators.
    Eur Heart J; 2006 Nov 20; 27(22):2661-6. PubMed ID: 17043060
    [Abstract] [Full Text] [Related]

  • 18. Impact of adding aspirin to beta-blocker and statin in high-risk patients undergoing major vascular surgery.
    Lau WC, Froehlich JB, Jewell ES, Montgomery DG, Eng KM, Shields TA, Henke PK, Eagle KA.
    Ann Vasc Surg; 2013 May 20; 27(4):537-45. PubMed ID: 23535525
    [Abstract] [Full Text] [Related]

  • 19. [Changes in the patterns of drug prescription for acute myocardial infarct. Comparison of 2 periods].
    Prieto JC, Corbalán R, Nazza C, Chávez E, Lanas F, Bartolucci J, Cumsille F, Grupo de Estudio Multicéntrico del Infarto.
    Rev Med Chil; 2001 May 20; 129(5):481-8. PubMed ID: 11464528
    [Abstract] [Full Text] [Related]

  • 20. Clinical benefit of early reperfusion therapy in patients with ST-elevation myocardial infarction usually excluded from randomized clinical trials (results from the Maximal Individual Therapy in Acute Myocardial Infarction Plus [MITRA Plus] registry).
    Koeth O, Zahn R, Gitt AK, Bauer T, Juenger C, Senges J, Zeymer U, Maximal Individual Therapy in Acute Myocardial Infarction Plus Study Group.
    Am J Cardiol; 2009 Oct 15; 104(8):1074-7. PubMed ID: 19801027
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.